CAS: 321695-57-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
NSC764414 REF: AN-AG00CNHECAS: 321695-57-2 | 96% | To inquire | Tue 21 May 24 | |
L002 REF: TM-T11807CAS: 321695-57-2 | 98.59% | 40.00 €~529.00 € | Tue 21 May 24 | |
L002 REF: 3D-WMA69557CAS: 321695-57-2 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: AN-AG00CNHE
5mg | 147.00 € | |
10mg | 252.00 € | |
25mg | 658.00 € | |
50mg | To inquire | |
100mg | To inquire | |
250mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
L002
CAS:321695-57-2
L002, a potent, cell-permeable, reversible, and specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of …
Formula:
C15H15NO5S
Purity:
98.59%
Color and Shape:
Solid
Molecular weight:
321.35
Ref: TM-T11807
2mg | 40.00 € | |
5mg | 59.00 € | |
10mg | 88.00 € | |
25mg | 167.00 € | |
50mg | 320.00 € | |
100mg | 529.00 € | |
1ml*10 (DMSO) | 65.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
L002
CAS:321695-57-2
L002 is a biochemical that is primarily used to treat lymphocytic leukemia. It is a …
Formula:
C15H15NO5S
Purity:
Min. 95%
Molecular weight:
321.35 g/mol
Ref: 3D-WMA69557
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024